Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS.
about
Using the nonhuman primate model of HCMV to guide vaccine developmentDivergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hostsQuantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infectionExperimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication.A seroprevalence study of primate workers for asymptomatic rhesus cytomegalovirus infection.Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression.Postnatal acquisition of primary rhesus cytomegalovirus infection is associated with prolonged virus shedding and impaired CD4+ T lymphocyte function.Rhesus cytomegalovirus is similar to human cytomegalovirus in susceptibility to benzimidazole nucleosidesExamining the species-specificity of rhesus macaque cytomegalovirus (RhCMV) in cynomolgus macaques.Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.Temple monkeys and health implications of commensalism, Kathmandu, Nepal.HIV-1 replication activates CD4+ T cells with specificities for persistent herpes virusesNonhuman primate models of intrauterine cytomegalovirus infection.Foamy virus infection in primates.Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaquesRhesus cytomegalovirus encodes seventeen microRNAs that are differentially expressed in vitro and in vivo.Rhesus CMV: an emerging animal model for human CMV.Human cytomegalovirus (CMV) in Africa: a neglected but important pathogenA heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus.A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism.Herpesvirus infections of laboratory macaques.Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatment.Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques.The infectious diseases consequences of monkey business.Genomic sequence of rhesus cytomegalovirus 180.92: insights into the coding potential of rhesus cytomegalovirus.Cytomegaloviral hypophysitis in a simian immunodeficiency virus-infected rhesus macaque (Macacca mulatta).Exploiting the natural history of cytomegalovirus to vaccinate against HIV.Measuring T-cell responses against LCV and CMV in cynomolgus macaques using ELISPOT: potential application to non-clinical testing of immunomodulatory therapeutics.Long-term safety outcome of systemic immunosuppression in pig-to-nonhuman primate corneal xenotransplantation
P2860
Q33584739-A0ED662F-93FC-40EE-9B5A-1A2909F9EC4AQ33707549-6B5740B9-22D8-492F-AC73-82D918595DF4Q33847798-7636828B-57E5-45AE-994C-B5AD59DE50F9Q33888012-5837CB92-9563-4D40-8131-F02CAFDC027DQ33953950-CB785871-5D2E-4704-8454-2FF4FC75E538Q34059228-DFA1FFB9-EC28-4899-A5B5-85BC589A6098Q34301868-598FB853-9C28-4563-92AE-51D3B78560F9Q34430261-AF585919-62D5-4663-8586-FEF73AC5B4E0Q35124909-822333B9-A5F8-4755-A912-8E4D72B7C625Q35231189-192A55F8-F72E-46F1-AC43-21561ED3ACFCQ35635231-C324CD54-51F6-41BE-94DC-0834B902DB06Q36026231-16FE01E7-AAE4-4892-AD8F-B857F52E2A20Q36039280-305B74E5-000A-4007-989B-CD60B202E54FQ36359753-BC96F96A-42C3-4D98-840B-9A22B4B54BDEQ36548744-79A6798A-080C-468E-BB9E-BB2B1828C3C7Q36666549-909DBDE5-D622-4858-997C-6C9A1C92383DQ36669211-69AEA30C-83F1-446A-BADB-27381980C1FCQ37056384-2099F110-9E73-4CE5-9211-63C91A8C7FC6Q37141399-6248AC0B-788A-4443-89C9-003A708606CAQ37355242-28D68EB0-2E5C-4E42-AA64-91CE3904214FQ37596973-657DF7DE-1705-447A-B890-63F1F69C8FF0Q37648751-B968AF7F-665C-4ECD-9446-EAE5F3D651A8Q39140795-DED3538F-8ABB-47AE-97FA-B88479A09EC8Q40059344-A9A6DE07-FE27-492D-BA55-AAC6446F9F39Q40584637-0A074D10-2858-43BE-865C-C6D482F884AAQ42067254-8D729FBD-BEB8-4826-B2B9-2CA9C9989EF3Q43085610-E364873B-E312-441B-9CAC-9DF71E0AD02DQ43409130-381DF14B-C851-41F8-8EAE-74AF7D9D0E8DQ43535500-AEDE68BF-F005-4447-AD34-412ABF0E3977Q45905220-3A0C1E6D-B128-482B-8935-BA637E7E5EE0Q57092575-0F3B419F-616B-4D0F-8C0C-6F9633AF63E5
P2860
Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Direct relationship between su ...... ovirus disease in simian AIDS.
@ast
Direct relationship between su ...... ovirus disease in simian AIDS.
@en
Direct relationship between su ...... ovirus disease in simian AIDS.
@nl
type
label
Direct relationship between su ...... ovirus disease in simian AIDS.
@ast
Direct relationship between su ...... ovirus disease in simian AIDS.
@en
Direct relationship between su ...... ovirus disease in simian AIDS.
@nl
prefLabel
Direct relationship between su ...... ovirus disease in simian AIDS.
@ast
Direct relationship between su ...... ovirus disease in simian AIDS.
@en
Direct relationship between su ...... ovirus disease in simian AIDS.
@nl
P2093
P2860
P1433
P1476
Direct relationship between su ...... ovirus disease in simian AIDS.
@en
P2093
Alicia Gomez-Yafal
Amitinder Kaur
Corrina L Hale
Jeffrey D Lifson
Meredith Simon
Michael Mach
Michelle Elliott
Nadine Kassis
Peter Barry
P2860
P304
P356
10.1128/JVI.77.10.5749-5758.2003
P407
P577
2003-05-01T00:00:00Z